Navigation Links
Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Date:12/17/2008

estors may participate in the conference call by dialing (877)879-6201 (domestic) or (719)325-4843 (international). To access the live webcast, please visit the company's website at http://www.cadencepharm.com and go to the Investor Relations page. A replay of the webcast will be available on the company's website beginning approximately two hours after the call.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, Acetavance(TM) (intravenous acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit http://www.cadencepharm.com.

Forward-Looking Statements

Statements included in this press release that are not a description of historical facts are forward-looking statements. Words such as "plans," "expects," "anticipates," "believes," and "will," and similar expressions, are intended to identify forward-looking statements, and are based on Cadence's current beliefs and expectations. Forward-looking statements include statements regarding: the timeframe in which Cadence anticipates filing an NDA seeking marketing authorization for Acetavance, and the timeframe in which the company expects to complete its analysis and announce the full results of its clinical trials of Acetavance. The inclusion of forward-looking statements should not be regarded as a representation by Cadence that any of its plans will be achieved. Actual results may differ materially from those set forth in
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
2. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
3. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... -- A clinical trial of hydroxyurea therapy for children ... early because the results show it is a safe ... the risk of stroke. The announcement about the ... the United States and Canada, was made this week ... (NHLBI). Researchers compared monthly blood transfusions with daily ...
(Date:11/22/2014)... Amy Norton HealthDay Reporter ... live in nursing homes may commonly deal with aggressive or ... The study of 10 centers in New York state found ... percent of residents were involved in some type of incident ... verbal clash, with someone yelling or cursing at another resident. ...
(Date:11/21/2014)... Nov. 20, 2014 (HealthDay News) -- The cost of ... percent in recent years, climbing to more than $322 ... increases in cost were seen with prediabetes care, which ... jumped 82 percent, the researchers added. In 2012, ... totaled more than $1,000 for every American. That total ...
(Date:11/21/2014)... PLYMOUTH and WOBURN, Mass. (PRWEB) November 21, 2014 ... will present two free workshops titled “Massachusetts Insurance Funding ... autism spectrum disorder (ASD) navigate their way through the ... must be covered under Massachusetts law and the most ... take place on Thursday, Dec. 4 from 6-8:00 p.m. ...
(Date:11/21/2014)... Recently, VogueQueen has released 18 ... promotion for the coming holiday season. People who register ... checking out. , The beach wedding dresses from VogueQueen.com ... the designs for the premium quality fabrics and dedicated ... good for the environment, they would bring more fun ...
Breaking Medicine News(10 mins):Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 2Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 3Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2Health News:Beach Wedding Dresses on Sale for the Coming Holiday Season at VogueQueen.com 2
... diseases such as flu, measles, whooping cough and other ... from coming back. // ,Non-Hodgkin's lymphoma is ... comes back, even after chemotherapy and eventually most of ... their lymphoma. ,The vaccine is made from a ...
... worldwide epidemic with the highest incidence rate and a high ... cases and 299 deaths in a ,population of 6.7 million. ... of SARS in Hong Kong. It seems the air may ... health care professionals must take the potential for airborne spread ...
... 400,000 Americans undergo balloon angioplasty to clear blocked arteries. In ... drug may change the outcome of the procedure. ... can to avoid a second open-heart surgery. Eight years ago, ... earlier this year, Bailey had the same kind of chest ...
... milk, supplements, or other dairy products may actually make you ... mother always told you to drink your milk so you ... ,Participants in the study who consumed more calcium lost ... a breakdown of fat occurs. However, if the body consumes ...
... new findings in animals suggest a potential treatment to ... injuries . ,"Our approach is based on a ... stress protein response," say specialists . Researchers say the ... the "secondary" cell death that occurs in the hours ...
... reaction of blood vessels in the eyes may offer insight into ... brain react to high blood pressure, a major risk factor for ... also known as Atacand, improves blood flow in the eye, which ... is the lining of the vessel walls and plays a key ...
Cached Medicine News:Health News:New Findings Could Reduce The Extent Of Spinal Cord Injuries 2
(Date:11/21/2014)... Texas , 21. November 2014 ... was sich am Morgen des 14. Februar 2014 zugetragen ... jedoch wohl kaum vergessen. Video - ... dass ich dabei war, mein morgendliches Training zu machen", ... waren zu der Zeit begeisterte Anhänger der ...
(Date:11/21/2014)... Nov. 20, 2014   Wellcentive , the ... for healthcare organizations, announced today being named one ... Intel Innovation Award .  Sponsored by Intel, the ... its fourth year, recognizes companies developing leading-edge technology ... delivery processes. Wellcentive,s Mason ...
(Date:11/18/2014)... Nov. 18, 2014 Respiratory Motion and IMI ... medical device and services providers in Japan ... Respiratory Motion,s innovative respiratory depression monitor, the ExSpiron™. As ... are working together to connect the clinical community in ... history of bringing innovative medical devices and new technology ...
Breaking Medicine Technology:Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4
... Calif., Jan. 7 Hyperion,Therapeutics, Inc., a ... commercialization of hepatology and gastrointestinal,therapies that address ... needs, today announced that William R. Ringo ... and will serve as Chairman., (Logo: ...
... Jan. 7 Baxter International,Inc. (NYSE: BAX ... to develop recombinant Factor IX proteins to treat ... Factor IX therapy for,treatment of acute bleeding episodes ... IX therapy for prophylaxis of bleeding in,hemophilia B ...
Cached Medicine Technology:William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman 2Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 2Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 3
... Induction Room., ,The Aestiva/5 Induction offers ... Aestiva/5 Induction has similar user interface as ... it easier for clinicians to use. The ... mixing, O2 failure alarm, N2O cutoff (with ...
... of performance and value., ,The Aestiva/5 ... of the Aestiva/5 anesthesia system (open architecture, ... Datex-Ohmedas newest anesthesia ventilation platform - the ... specifically engineered to allow for ventilation of ...
... The S/5 Aespire was developed using ... development close and continuous collaboration ... performance of the 7100 Ventilator with ... system solution designed for clinicians throughout ...
The Electronic bag and bottle ventilator especially designed for your circle system needs. Provides the anaesthetist with a wide range of economic anaesthesia solutions with the following outstanding...
Medicine Products: